Updated:
Inozyme Pharma, Inc.
Inozyme Pharma, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001693011, and its reported industry is...
Overview
Inozyme Pharma, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001693011, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-03-10, it reported net income of USD -102,024,000; total assets of USD 123,182,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Inozyme Pharma, Inc.
- Former names in filing history
- Inozyme Pharma, LLC (2017-01-05 to 2017-01-05)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Boston, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001693011
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2024USD | -$102.0M | $123.2M | $21.1M | -$91.9M | |
| FY2023USD | -$71.2M | $200.8M | $34.6M | -$70.7M | |
| FY2022USD | -$67.1M | $139.2M | $32.9M | -$57.8M | |
| FY2021USD | -$56.6M | $123.5M | $23.3M | -$48.2M |
FY2022. Net income: shown as originally filed; later filings report different values for the same periods.
FY2021. Net income: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| SC 13G | — | SCHEDULE 13G | |
| SC 13G | — | Form SC 13G |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Inozyme Pharma, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.